NASDAQ:IDRA - Idera Pharmaceuticals Price Target & Analyst Ratings

Sign in or create an account to add this stock to your watchlist.
$1.01 -0.05 (-4.72 %)
(As of 07/16/2018 04:48 AM ET)
Previous Close$1.01
Today's Range$1.00 - $1.10
52-Week Range$1.02 - $2.87
Volume3.30 million shs
Average Volume1.90 million shs
Market Capitalization$219.48 million
P/E Ratio-2.40
Dividend YieldN/A
Beta2.42

Analyst Ratings

Idera Pharmaceuticals (NASDAQ:IDRA) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
4 Wall Street analysts have issued ratings and price targets for Idera Pharmaceuticals in the last 12 months. Their average twelve-month price target is $4.00, suggesting that the stock has a possible upside of 296.04%. The high price target for IDRA is $4.00 and the low price target for IDRA is $4.00. There are currently 4 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $4.00$4.00$4.3333$5.40
Price Target Upside: 296.04% upside125.99% upside114.52% upside172.73% upside

Idera Pharmaceuticals (NASDAQ:IDRA) Consensus Price Target History

Price Target History for Idera Pharmaceuticals (NASDAQ:IDRA)

Idera Pharmaceuticals (NASDAQ:IDRA) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
6/13/2018Robert W. BairdLower Price TargetOutperform ➝ Outperform$5.00 ➝ $4.00LowView Rating Details
6/13/2018JMP SecuritiesLower Price TargetOutperform ➝ Positive$8.00 ➝ $4.00LowView Rating Details
5/10/2018HC WainwrightReiterated RatingBuy$4.00LowView Rating Details
9/12/2017Piper Jaffray CompaniesReiterated RatingBuy$4.00LowView Rating Details
4/11/2017WedbushReiterated RatingOutperform$6.00LowView Rating Details
11/29/2016CowenReiterated RatingOutperformN/AView Rating Details
10/7/2016S&P Equity ResearchBoost Price Target$1.86 ➝ $2.10N/AView Rating Details
(Data available from 7/16/2016 forward)
This page was last updated on 7/16/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.